RPL23A and cancer: Besides, interferon gamma response and interferon alpha were enriched in the results of GSEA concentrating RPL23A indicating that RPL23A might have significant roles in immune-related pathways, besides, therapies target Myc could also enhance the immunotherapy in cancers 24.